{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:03:07Z","timestamp":1753880587231,"version":"3.41.2"},"reference-count":28,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/AuthorWarrantyLicense.v1"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100009054","name":"U.S. President's Emergency Plan for AIDS Relief","doi-asserted-by":"publisher","award":["HHS\/CDC Head Quarter funding"],"award-info":[{"award-number":["HHS\/CDC Head Quarter funding"]}],"id":[{"id":"10.13039\/100009054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009054","name":"U.S. President's Emergency Plan for AIDS Relief","doi-asserted-by":"publisher","award":["6 NU2GGH001972-04-02"],"award-info":[{"award-number":["6 NU2GGH001972-04-02"]}],"id":[{"id":"10.13039\/100009054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2022,6,29]]},"abstract":"<jats:p>This HIVDR genotyping assay works for both plasma and DBS samples, requires low sample input, and is sensitive. This assay has the potential to be a user-friendly and cost-effective HIVDR assay because of its partially multiplexed design. Application of this genotyping assay will help HIVDR monitoring in HIV high-burdened countries using a DGT-based HIV drug regimen recommended by the U.S. President's Emergency Plan for AIDS Relief and the WHO.<\/jats:p>","DOI":"10.1128\/spectrum.01776-21","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T13:00:56Z","timestamp":1651755656000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT)"],"prefix":"10.1128","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3306-1462","authenticated-orcid":true,"given":"Joshua","family":"DeVos","sequence":"first","affiliation":[{"name":"International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"McCarthy","sequence":"additional","affiliation":[{"name":"CDC Kenya, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Sewe","sequence":"additional","affiliation":[{"name":"HIV Research Laboratory, Kenya Medical Research Institute-Center for Global Health Research, Kisumu, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Akinyi","sequence":"additional","affiliation":[{"name":"HIV Research Laboratory, Kenya Medical Research Institute-Center for Global Health Research, Kisumu, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthoni","family":"Junghae","sequence":"additional","affiliation":[{"name":"CDC Kenya, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valarie","family":"Opollo","sequence":"additional","affiliation":[{"name":"HIV Research Laboratory, Kenya Medical Research Institute-Center for Global Health Research, Kisumu, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janin","family":"Nouhin","sequence":"additional","affiliation":[{"name":"Stanford University, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Shafer","sequence":"additional","affiliation":[{"name":"Stanford University, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement","family":"Zeh","sequence":"additional","affiliation":[{"name":"International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Ramos","sequence":"additional","affiliation":[{"name":"International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Alexander","sequence":"additional","affiliation":[{"name":"International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Chang","sequence":"additional","affiliation":[{"name":"International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"UNAIDS. 2014. 90\u201390-90 An ambitious treatment target to help end the AIDS epidemic. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/90-90-90_en.pdf."},{"key":"e_1_3_2_3_2","unstructured":"UNAIDS. 2014. Fast-Track - Ending the AIDS epidemic by 2030. https:\/\/www.unaids.org\/en\/resources\/documents\/2014\/JC2686_WAD2014report."},{"key":"e_1_3_2_4_2","unstructured":"UNAIDS. 2020. Global HIV & AIDS statistics - 2020 fact sheet. https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"e_1_3_2_5_2","unstructured":"WHO. 2017. HIV drug resistance report 2017. https:\/\/www.who.int\/publications\/i\/item\/9789241512831."},{"key":"e_1_3_2_6_2","unstructured":"WHO. 2019. HIV drug resistance report 2019. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-19.21."},{"key":"e_1_3_2_7_2","unstructured":"WHO. 2019. Update of recommendations on first- and second-line antiretroviral regimens Policy brief. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-19.15."},{"key":"e_1_3_2_8_2","unstructured":"Doherty M. 2020. Introduction and overview of WHO diagnostics treatment and care priorities. 23rd International AIDS Conference."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224292"},{"key":"e_1_3_2_10_2","unstructured":"ABL BW. 2015. Advanced Biological Laboratories (ABL) launches HIV and HCV DeepChek SingleRound genotyping and sequencing assays. https:\/\/www.businesswire.com\/news\/home\/20151106005788\/en\/Advanced-Biological-Laboratories-ABL-Launches-HIV-and-HCV-DeepChek%C2%AE-SingleRound-Genotyping-and-Sequencing-Assays."},{"key":"e_1_3_2_11_2","unstructured":"VELA. 2019. Package insert Sentosa SQ HIV-1 genotyping reagents. https:\/\/www.fda.gov\/media\/132293\/download."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028184"},{"key":"e_1_3_2_13_2","unstructured":"Thermo Fisher Scientific. 2021. Genotyping of HIV-1 to detect drug resistance. https:\/\/www.thermofisher.com\/us\/en\/home\/life-science\/sequencing\/sanger-sequencing\/applications\/genotyping-hiv-detect-drug-resistance.html."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2016.12.008"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02347-12"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/240407"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis015"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203296"},{"key":"e_1_3_2_19_2","unstructured":"Qiagen. 2020. QIAamp viral RNA mini handbook."},{"key":"e_1_3_2_20_2","volume-title":"Laboratory-based survey of acquired HIV drug resistance using remnant viral load specimens","author":"WHO","year":"2021","unstructured":"WHO. 2021. Laboratory-based survey of acquired HIV drug resistance using remnant viral load specimens. WHO, Geneva, Switzerland."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu020"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232419"},{"key":"e_1_3_2_23_2","unstructured":"NIH. 2021. Duke virology quality assurance (VQA) HIV-1 drug resistance sequencing participation requirements and scoring procedures. https:\/\/www.hanc.info\/content\/dam\/hanc\/documents\/laboratory\/vqa-resources\/VQA_HIV-1_GEN_DR_PT_Information%20v2.0_20211101.pdf."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2008.08.021"},{"key":"e_1_3_2_25_2","unstructured":"Biomerieux. 2005. Nuclisens easymag. https:\/\/www.biomerieuxindia.in\/product\/nuclisensr-easymagr."},{"key":"e_1_3_2_26_2","article-title":"Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool","volume":"50","author":"Woods Cjb CK","year":"2012","unstructured":"Woods Cjb CK, Liu TF, Chui CKS, Chu AL, Wynhoven B, Hall TA, Trevino C, Shafer RW, Harrigana PR. 2012. Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool. J Clin Microbiol 50.","journal-title":"J Clin Microbiol"},{"key":"e_1_3_2_27_2","unstructured":"Hall T. 2008. BioEdit. https:\/\/thalljiscience.github.io\/."},{"key":"e_1_3_2_28_2","unstructured":"Stanford University. 2008. HIV drug resistance database. https:\/\/hivdb.stanford.edu\/."},{"key":"e_1_3_2_29_2","unstructured":"WHO. 2020. WHO HIVResNet HIV drug resistance laboratory operational framework. https:\/\/www.who.int\/publications\/i\/item\/978-92-4-000987-5."}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01776-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01776-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T19:10:55Z","timestamp":1723403455000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.01776-21"}},"subtitle":[],"editor":[{"given":"Heba H.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6,29]]}},"alternative-id":["10.1128\/spectrum.01776-21"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.01776-21","relation":{},"ISSN":["2165-0497"],"issn-type":[{"type":"electronic","value":"2165-0497"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"2021-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01776-21"}}